Cipta Sarana Medika Tbk. vs Lupromax Pelumas Indonesia Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Lupromax Pelumas Indonesia Tbk. trades at Rp118 (market cap 77.35B, 1.43M 24h volume). The key difference: Cipta Sarana Medika Tbk. is far larger — about 2× Lupromax Pelumas Indonesia Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (8.21M versus 1.43M). Which is the better fit depends on your goals.
| DKHH | LMAX | |
|---|---|---|
Market Cap | 158.12B | 77.35B |
Volume | 8.21M | 1.43M |
Lot | 82.15K | 14.32K |
Turnover | 515.2M | 165.87M |
Average Price | 62.72 | 115.81 |
Value | 515.2M | 165.87M |
Indicative Equilibrium Price | 63 | 118 |
Indicative Equilibrium Volume | 1.33K | 2K |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Lupromax Pelumas Indonesia Tbk formerly PT Karya Pelumas Indonesia (the Company) was established based on Notarial Deed No. 42 dated February 27, 2017 of Meissie Pholuan, S.H., notary in Jakarta. The Company started its commercial operations in 2017.
Read more on LMAX →